Imbrave150 Trial Combination Therapy In Advanced Hcc

Summary

The role of sorafenib in the first-line Peter R. Galle, MD, PhD, Johannes Gutenberg University, Mainz, Germany, shares updated efficacy data from the Phase III ... In the past five years, the use of immunotherapeutic agents for Daneng Li, MD, of City of Hope National Medical Center, Duarte, CA, discusses results from older adults enrolled in James J. Harding, MD, regional director of Early Drug Development at Memorial Sloan Kettering Cancer Center, discusses the ... A review outlining several clinical Daneng Li, MD, discusses the subgroup analysis of the phase 3 Michael J. Pishvaian, MD, PhD, a gastrointestinal oncologist and head of the Phase I Program at the Georgetown Lombardi ... Richard S. Finn, MD, discusses the significance of the results presented on the recent Dr. Finn, Professor, Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, Director, Signal ...